Chemoinformaics analysis of 1,3,6,10-DODECATETRAENE
| Molecular Weight | 162.276 | nRot | 6 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 4 |
| Exact Molecular Weight | 162.141 | nRing | 0 |
| Solubility: LogS | -4.157 | nHRing | 0 |
| Solubility: LogP | 4.621 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 32.0423 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.314 |
| Synth | 3.322 |
| Natural Product Likeliness | 2.684 |
| NR-PPAR-gamma | 0.099 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.004 |
| CACO-2 | -4.446 |
| MDCK | 0.0000228 |
| BBB | 0.696 |
| PPB | 0.916135 |
| VDSS | 2.967 |
| FU | 0.0704029 |
| CYP1A2-inh | 0.727 |
| CYP1A2-sub | 0.22 |
| CYP2c19-inh | 0.251 |
| CYP2c19-sub | 0.596 |
| CYP2c9-inh | 0.046 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.234 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.235 |
| CYP3a4-sub | 0.196 |
| CL | 10.275 |
| T12 | 0.454 |
| hERG | 0.004 |
| Ames | 0.767 |
| ROA | 0.032 |
| SkinSen | 0.975 |
| Carcinogencity | 0.927 |
| EI | 0.994 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.039 |
| Antiviral | No |
| Prediction | 0.829475 |